BioAgilytix
BioAgilytix added to its leadership team with the appointment of Sean Blake to chief information officer.
With more than 20 years of IT leadership experience, Blake will lead the “development, assessment, and execution of critical IT strategies” across BioAgilytix’s operations, according to the company.
Blake was previously the director of information systems at BioCryst Pharmaceuticals.
In a statement, Blake said he looks forward to “implementing technological systems that are innovative for the company and that will support and help accelerate BioAgilytix’s current growth trajectory.”
Also in June, BioAgilytix CEO James Datin was named to FSD Pharma’s board of directors.
The Canada-based company focuses on the development of indoor grown, pharmaceutical grade cannabis and the research and development of cannabinoid-based treatments for central nervous system disorders.
Speaking to the appointment, Datin said: “The opportunity to contribute at this stage in FSD’s growth is exciting. As a biotech life sciences executive with extensive experience as a member of more than 30 Board of Directors of PE backed and public companies, I am looking forward to helping the leadership and Biosciences Division in realizing FSD’s vision to meaningfully advance into the biopharmaceutical industry.”